Eledon Pharmaceuticals
ELDN
ELDN
32 hedge funds and large institutions have $27.6M invested in Eledon Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $69K
Holders
32
Holding in Top 10
–
Calls
–
Puts
$69K
Top Buyers
| 1 | +$3.74M | |
| 2 | +$490K | |
| 3 | +$434K | |
| 4 |
B
Bailard
Foster City,
California
|
+$109K |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$70.8K |
Top Sellers
| 1 | -$5.91M | |
| 2 | -$2.22M | |
| 3 | -$426K | |
| 4 |
Two Sigma Investments
New York
|
-$224K |
| 5 |
Two Sigma Advisers
New York
|
-$172K |